Deferoxamine
Deferoxamine is a clinically used iron chelator for treating acute iron toxicity and a research tool for studying iron metabolism. It is widely applied in neuroscience, oncology, and immunology research, demonstrating efficacy in models of traumatic brain injury, cancer cell death (apoptosis/autophagy), and inflammation, both in vitro and in vivo.
Product Specifications
CAS Number
70-51-9
Product Name Alternative
Antioxidant, Apoptosis, Autophagy, Desferrioxamine B, Deferoxamine, Deferoxamine B, HIF
Field of Research
Purity
99.66% (May vary between batches)
Solubility
DMSO: 12.4 mg/mL (22.12 mM), sonication and heating are recommended. H2O: 7.14 mg/mL (12.73 mM), sonication is recommended.
Smiles
O=C (NCCCCCN (O) C (=O) C) CCC (=O) N (O) CCCCCNC (=O) CCC (=O) N (O) CCCCCN
Molecular Formula
C25H48N6O8
Molecular Weight
560.68
Storage Conditions
Powder: -20°C for 3 years. In solvent: -80°C for 1 year.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Strain Anka PBANKA_1012900 Antibody Fluoro594 Conjugated
RANBP3, NT (RANBP3, Ran-binding protein 3) (MaxLight 550) discontinued
Recombinant Neisseria meningitidis serogroup A / serotype 4A Protease HtpX homolog (htpX)
Recombinant Neisseria meningitidis serogroup A / serotype 4A Protease HtpX homolog (htpX)